Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Blanchette

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioconjugate Chemistry|July 24, 2020
Nanolipoprotein Particles as a Delivery Platform for Fab Based TherapeuticsMartine Darwish, Whitney Shatz, Brandon Leonard, et al.
Protein Science : a Publication of the Protein Society|June 12, 2013
Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistryWei He, Juntao Luo, Feliza Bourguet, et al.
Bioconjugate Chemistry|April 9, 2024
Adapting Ferritin, a Naturally Occurring Protein Cage, to Modulate Intrinsic Agonism of OX40Whitney Shatz-Binder, Caleigh M Azumaya, Brandon Leonard, et al.
Plos One|June 29, 2019
Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eyeWhitney Shatz, Philip E Hass, Nikhil Peer, et al.
Nature Communications|November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicityYu Kong, Christopher M Rose, Ashley A Cass, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMaxine R Nelson, Marina Kovaliov, Priyanka Singh, et al.
Frontiers in Immunology|September 26, 2022
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancerDavid G Coffey, Yuexin Xu, Andrea M H Towlerton, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Nature Immunology|March 25, 2022
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccinesSiri Tahtinen, Ann-Jay Tong, Patricia Himmels, et al.
Nature Biotechnology|October 19, 2023
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor typesHem R Gurung, Amy J Heidersbach, Martine Darwish, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioconjugate Chemistry|July 24, 2020
Nanolipoprotein Particles as a Delivery Platform for Fab Based TherapeuticsMartine Darwish, Whitney Shatz, Brandon Leonard, et al.
Protein Science : a Publication of the Protein Society|June 12, 2013
Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistryWei He, Juntao Luo, Feliza Bourguet, et al.
Bioconjugate Chemistry|April 9, 2024
Adapting Ferritin, a Naturally Occurring Protein Cage, to Modulate Intrinsic Agonism of OX40Whitney Shatz-Binder, Caleigh M Azumaya, Brandon Leonard, et al.
Plos One|June 29, 2019
Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eyeWhitney Shatz, Philip E Hass, Nikhil Peer, et al.
Nature Communications|November 21, 2019
Transposable element expression in tumors is associated with immune infiltration and increased antigenicityYu Kong, Christopher M Rose, Ashley A Cass, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentMaxine R Nelson, Marina Kovaliov, Priyanka Singh, et al.
Frontiers in Immunology|September 26, 2022
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancerDavid G Coffey, Yuexin Xu, Andrea M H Towlerton, et al.
Nature Communications|December 31, 2024
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApolloWilliam John Thrift, Nicolas W Lounsbury, Quade Broadwell, et al.
Nature Immunology|March 25, 2022
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccinesSiri Tahtinen, Ann-Jay Tong, Patricia Himmels, et al.
Nature Biotechnology|October 19, 2023
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor typesHem R Gurung, Amy J Heidersbach, Martine Darwish, et al.
Pageof 2